Filing Details
- Accession Number:
- 0001062993-16-012532
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-29 17:15:11
- Reporting Period:
- 2016-11-28
- Filing Date:
- 2016-11-29
- Accepted Time:
- 2016-11-29 17:15:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1355189 | Thomas Wegman | C/O Biospecifics Technologies Corp. 35 Wilbur Street Lynbrook NY 11563 | President | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.001 Par Value | Disposition | 2016-11-28 | 11,055 | $48.04 | 964,824 | No | 4 | S | Direct | |
Common Stock, $.001 Par Value | Disposition | 2016-11-29 | 8,945 | $48.32 | 955,879 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The selling price of $48.0369 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $47.50 to $49.40. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The selling price of $48.3161 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $48.25 to $48.77. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.